Metastatic ErbB2 (HER2) tumour burden was reduced by 75% in BCL3-null mice and this was recapitulated in allografts of BCL3-null tumour cells into wild-type recipient mice, confirming the tumour cell autonomous effects of BCL3 on the metastatic process [44]. The gene discussed is BCL3; the disease is neoplasm.